The Future of Cardiovascular Epidemiology.
From National Heart Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA (R.S.V., E.J.B.); Evans Department of Medicine, Whitaker Cardiovascular Institute (R.S.V., E.J.B.) and Preventive Medicine and Cardiology Sections, Department of Medicine (R.S.V., E.J.B.), Boston University School of Medicine, MA; and Department of Epidemiology, Boston University School of Public Health, MA (R.S.V., E.J.B.). vasan@bu.edu.
Ramachandran S
RS
Vasan
From National Heart Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA (R.S.V., E.J.B.); Evans Department of Medicine, Whitaker Cardiovascular Institute (R.S.V., E.J.B.) and Preventive Medicine and Cardiology Sections, Department of Medicine (R.S.V., E.J.B.), Boston University School of Medicine, MA; and Department of Epidemiology, Boston University School of Public Health, MA (R.S.V., E.J.B.).
Emelia J
EJ
Benjamin
D002309:Cardiology / Q000639:trends*; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000235:genetics / Q000401:mortality / Q000628:therapy; D004812:Epidemiologic Methods; D005544:Forecasting; D020022:Genetic Predisposition to Disease; D006801:Humans; D033183:Interdisciplinary Communication; D000070516:Intersectoral Collaboration; D010641:Phenotype; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors
cardiovascular diseases; epidemiology